An 18 year old female had a history of Vitiligo vulgaris for 10 years and had clinical stability for one year. The lesions that were treated were on the medial aspect of the left foot.

A small split-thickness biopsy was taken with a hand dermatome from the upper lateral thigh and processed with ReCell ® to obtain a fresh cell suspension of keratinocytes and melanocytes. Under local anaesthetic, the lesion was dermabraded with a diamond burr until pin-point bleeding was reached. After haemostasis was achieved by compression with a moistened gauze, the cell suspension was sprayed
onto the prepared lesion and properly dressed.
Note: Lesions treated with ReCell ® are marked SL (for the suspension with ReCell ® Buffer Solution) while the unmarked lesions were treated
during the same procedure with conventional MKT.
18-weeks post-treatment, lesions treated by both ReCell ® and MKT had repigmented completely.
Recell Benefits
This case was part of a series aimed at evaluating ReCell ® in comparison to the technique well established by Dr. Mulekar (see references). The patient had lesions of similar location treated with the two techniques on the same day. The main difference lies in the process (lab in a box vs. purpose build lab), cell concentration of the suspension (ReCell ® uses a greater expansion ratio) and medium used for the suspension. However, the results were found fully comparable.

Treating stable Vitiligo vulgaris
ReCell can be used in the treatment of stable generalised Vitiligo to restore pigmentation. Significantly larger areas can be treated than with conventional methods.
Stable Vitiligo vulgaris
Vitiligo vulgaris on medial left foot

Treating stable segmental Vitiligo
ReCell can be used in the treatment of stable segmental Vitiligo to restore pigmentation.